Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Given Average Rating of “Buy” by Analysts

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have received a consensus recommendation of “Buy” from the seventeen research firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, six have given a hold rating, seven have issued a buy rating and one has issued a strong buy rating on the company. The average 12-month price objective among brokers that have covered the stock in the last year is $63.66.

Several equities analysts have weighed in on the company. Citigroup raised their price objective on Acadia Healthcare from $73.00 to $77.00 and gave the company a “buy” rating in a research note on Wednesday, August 4th. TheStreet upgraded Acadia Healthcare from a “c+” rating to a “b-” rating in a research note on Monday, August 2nd. Credit Suisse Group upgraded Acadia Healthcare from a “neutral” rating to an “outperform” rating and set a $68.00 target price on the stock in a research note on Monday. Cowen started coverage on Acadia Healthcare in a research note on Thursday, September 9th. They set an “outperform” rating and a $79.00 target price on the stock. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on Acadia Healthcare from $62.00 to $70.00 and gave the stock a “hold” rating in a research note on Wednesday, August 4th.

NASDAQ:ACHC traded up $0.53 during trading hours on Tuesday, hitting $63.74. 362,219 shares of the company traded hands, compared to its average volume of 477,791. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.61. The firm’s 50-day simple moving average is $62.97 and its 200-day simple moving average is $62.11. Acadia Healthcare has a one year low of $27.07 and a one year high of $68.65. The company has a market cap of $5.73 billion, a PE ratio of -8.15, a PEG ratio of 6.90 and a beta of 1.56.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Sunday, August 1st. The company reported $0.71 earnings per share for the quarter, beating the consensus estimate of $0.63 by $0.08. Acadia Healthcare had a positive return on equity of 11.70% and a negative net margin of 27.61%. The business had revenue of $582.20 million for the quarter, compared to analysts’ expectations of $560.88 million. During the same period last year, the business earned $0.54 EPS. The business’s revenue was up 18.5% on a year-over-year basis. As a group, equities research analysts expect that Acadia Healthcare will post 2.6 EPS for the current year.

A number of hedge funds have recently bought and sold shares of ACHC. Profund Advisors LLC grew its holdings in shares of Acadia Healthcare by 3.0% during the first quarter. Profund Advisors LLC now owns 5,940 shares of the company’s stock worth $339,000 after purchasing an additional 175 shares in the last quarter. CWM Advisors LLC grew its holdings in shares of Acadia Healthcare by 3.1% during the second quarter. CWM Advisors LLC now owns 5,940 shares of the company’s stock worth $373,000 after purchasing an additional 180 shares in the last quarter. Cresset Asset Management LLC grew its holdings in shares of Acadia Healthcare by 3.5% during the second quarter. Cresset Asset Management LLC now owns 5,342 shares of the company’s stock worth $336,000 after purchasing an additional 180 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its position in Acadia Healthcare by 0.6% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 29,895 shares of the company’s stock worth $1,876,000 after buying an additional 191 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. lifted its position in Acadia Healthcare by 0.6% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 33,608 shares of the company’s stock worth $2,109,000 after buying an additional 201 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Co, Inc engages in the provision of behavioral healthcare services. It operates through the following business segments: United States (U.S.) Facilities and the United Kingdom (U.K.) Facilities. The U.S. Facilities segment classified in the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; residential treatment centers; and outpatient community-based services.

Recommended Story: Debt-To-Equity Ratio

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.